An interview with Michael M. Gottesman, M.D. Interview by Vicki Glaser

Assay Drug Dev Technol. 2009 Jun;7(3):213-8. doi: 10.1089/adt.2009.9991.

Abstract

Dr. Michael Gottesman obtained his M.D. from Harvard University Medical School, completed his internship and residency in medicine at the Peter Bent Brigham Hospital in Boston, and received his postdoctoral research training in molecular genetics with Martin Gellert at the National Institutes of Health (NIH). After a year as an assistant professor in the Department of Anatomy at Harvard, he moved to the NIH in 1976. He currently serves as the NIH Deputy Director for Intramural Research as well as Chief of the Laboratory of Cell Biology.

Publication types

  • Interview

MeSH terms

  • ATP Binding Cassette Transporter, Subfamily B, Member 1 / genetics
  • Animals
  • Antineoplastic Agents / therapeutic use
  • Drug Resistance, Multiple
  • Drug Resistance, Neoplasm
  • Drug Screening Assays, Antitumor
  • Genomics
  • Humans
  • National Institutes of Health (U.S.) / organization & administration*
  • National Institutes of Health (U.S.) / trends
  • Neoplasms / drug therapy
  • Neoplasms / pathology
  • Research / trends
  • Research Support as Topic
  • Small Molecule Libraries
  • United States

Substances

  • ATP Binding Cassette Transporter, Subfamily B, Member 1
  • Antineoplastic Agents
  • Small Molecule Libraries